DermTech’s Pigmented Lesion Assay Could Detect Melanoma at Its Earliest Stages, TRUST Study Suggests
Results of DermTech Inc's TRUST study were published recently in SKIN: The Journal Of Cutaneous Medicine, the company announces.
Results of DermTech Inc's TRUST study were published recently in SKIN: The Journal Of Cutaneous Medicine, the company announces.
PermeaDerm reduced product cost by 70% and preparation time by 95.7% compared with cadaveric allograft while achieving comparable clinical outcomes in a randomized study.
The injectable, known as Restylane Contour in the US, achieved a 94.4% responder rate at six months, with improvements sustained through 12 months.
A study found that patients who underwent liposuction with helium plasma radiofrequency technology reported higher satisfaction with abdominal appearance and underwent fewer revision procedures and abdominoplasties compared to patients treated with liposuction alone.
Read MoreNew research behind the Skin Quality Index highlights how inconsistent terminology may affect aesthetic consultations, treatment planning, and patient understanding.
Read MoreClinical and histological data show reduced lesions and dermal remodeling after treatment, but underlying markers of cancerization remained unchanged.
Read MoreResearch published in the Journal of Cosmetic Dermatology highlights the stability and skin-mimicking properties of lipid-soluble vitamin C derivatives.
Read MoreApplications are now being accepted for the 2026–2027 American Board of Medical Specialties Scholars Program.
Read MoreAllergan Aesthetics presented new research at AMWC 2026 indicating a shift toward subtle, natural-looking outcomes in hyaluronic acid injectables and emphasizing the role of personalized treatment approaches.
Read MoreNew framework aims to address inconsistencies in how skin quality is described during aesthetic consultations.
Read MoreAn analysis of national search trends and surgeon workforce data highlights rising patient interest in aesthetic procedures across Southern, Midwestern, and rural regions where access to board-certified plastic surgeons remains limited.
Read MorePhase 4 study data presented at the American Academy of Pain Medicine PainConnect 2026 meeting reported that more than 90% of patients undergoing aesthetic or reconstructive procedures remained opioid-free when treated with Journavx as part of multimodal pain therapy.
Read MoreResearchers found participation among underrepresented racial and ethnic groups increased far beyond national population growth.
Read MoreA national survey shows how GLP-1–associated weight loss is driving facial volume loss, laxity, and wrinkles—and why fillers and neuromodulators anchor treatment for this growing patient group. Plastic Surgery Practice talks to one of the study’s authors to break down the findings and what they mean for treatment planning in today’s aesthetic practice.
Read MoreA principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.
Read MoreTwo new clinical analyses examine how simultaneous, on-label 64-unit onabotulinumtoxinA treatment of the upper face delivers natural-looking, durable, and predictable outcomes across diverse patient populations and multiple treatment cycles.
Read MoreA machine learning model analyzed data from more than 700 procedures and predicted intraoperative blood loss with 94% accuracy
Read MoreA study finds patients with a history of COVID had higher rates of venous thromboembolism following panniculectomy, even with standard clot prevention.
Read More